Skip to main content
. 2002 Nov;54(5):535–539. doi: 10.1046/j.1365-2125.2002.01692.x

Table 1.

Mean ± s.e. mean (95% confidence interval) concentrations of 8-MOP in epidermis (section 1–5) and dermis (section 6–12).

8-MOP concentrations 8-MOP administration
(pg mm−3) Cream Bath Oral
Epidermis (Time 1) 128.0 ± 22.6* 56.7 ± 25.3 27.0 ± 25.3
(77.6, 178.4) (0.4, 113.1) (−29.3, 83.3)
Dermis (Time 1) 7.1 ± 2.8* 8.8 ± 3.1* 20.0 ± 3.1
(0.9, 13.3) (1.8, 15.7) (13.1, 27.0)
Epidermis (Time 2) 58.2 ± 11.5 39.6 ± 12.9 30.0 ± 12.9
(32.4, 83.9) (10.8, 68.3) (1.8, 58.8)
Dermis (Time 2) 8.4 ± 2.0* 7.7 ± 2.2* 16.2 ± 2.2
(4.0, 12.8) (2.8, 12.6) (11.2, 21.1)
Epidermis (Time 3) 58.6 ± 8.4 42.4 ± 9.4 28.5 ± 9.4
(39.8, 77.4) (21.4, 63.5) (7.5, 49.6)
Dermis (Time 3) 1 5.8 ± 2.6 8.1 ± 2.9 12.9 ± 2.9
(10.1, 21.7) (1.6, 14.5) (6.5, 19.3)

Time 1: directly after cream or bath application time or 1 h after oral administration. Time 2: 0.5 h after the end of cream or bath, 2 h after oral administration. Time 3: 1 h after the end of cream or bath, 3 h after oral administration.

*

Statistically significant mean difference vs oral administration with P < 0.05.